Medpace Holdings, Inc.

Total Valuation

Medpace Holdings, Inc. carries a market capitalization of 13.35B, placing it among publicly traded companies globally. Its enterprise value stands at 13.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Medpace Holdings, Inc. currently has 28.56M shares outstanding.

Valuation Ratios

Medpace Holdings, Inc. trades at a trailing price-to-earnings ratio of 29.59. The price-to-sales ratio is 5.09, and the price-to-book ratio stands at -40.56.

Enterprise Valuation

On an enterprise value basis, Medpace Holdings, Inc. trades at an EV/EBITDA multiple of 22.15 and an EV/FCF ratio of 17.60. The EV/Sales ratio of 4.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.26 provides insight into valuation relative to core operating earnings.

Financial Position

Medpace Holdings, Inc. maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Taxes

Over the trailing twelve months, Medpace Holdings, Inc. has paid 111.40M in income taxes, reflecting an effective tax rate of 19.48.

Stock Price Statistics

Medpace Holdings, Inc.'s stock has gained approximately 55.27278% over the past 52 weeks. The 50-day moving average sits at 454.49, while the 200-day moving average is 512.71.

Income Statement

Over the trailing twelve months, Medpace Holdings, Inc. generated 2.68B in revenue and converted that into 460.40M in net income, yielding earnings per share of 15.89. EBITDA reached 591.02M, while operating income came in at 562.92M.

Balance Sheet

Medpace Holdings, Inc. holds 652.68M in cash and equivalents against 122.26M in total debt, resulting in a net debt position of -652.68M. Total book value stands at -335.82M, with working capital of -205.96M providing operational flexibility.

Cash Flow

Medpace Holdings, Inc. produced 739.18M in operating cash flow over the past twelve months. After subtracting -4.54M in capital expenditures, free cash flow totaled 734.64M - equivalent to 25.90 per share.

Margins

Medpace Holdings, Inc. operates with a gross margin of 29.07, reflecting its pricing power and cost economics. The operating margin of 21.02 and net profit margin of 17.19 provide insight into operational efficiency.

Dividends & Yields

Scores

Medpace Holdings, Inc. posts an Altman Z-Score of 8.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.